Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-09

Clinical Trial Update: Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial evaluating the combination of bicalutamide and anastrozole for testotoxicosis (precocious puberty) has completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)
  • bicalutamide (bicalutamide)

Snippet

Sponsor: AstraZeneca | Conditions: Puberty, Precocious | Phase 2 | Status: COMPLETED | Results posted: 2009-07-09